FR2342724A1 - Derives de 16,16-spirocycloalkylprostaglandines, leur preparation et leurs utilisations therapeutiques - Google Patents

Derives de 16,16-spirocycloalkylprostaglandines, leur preparation et leurs utilisations therapeutiques

Info

Publication number
FR2342724A1
FR2342724A1 FR7620333A FR7620333A FR2342724A1 FR 2342724 A1 FR2342724 A1 FR 2342724A1 FR 7620333 A FR7620333 A FR 7620333A FR 7620333 A FR7620333 A FR 7620333A FR 2342724 A1 FR2342724 A1 FR 2342724A1
Authority
FR
France
Prior art keywords
spirocycloalkylprostaglandin
derivatives
preparation
therapeutic uses
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7620333A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FR2342724A1 publication Critical patent/FR2342724A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/13—Monohydroxylic alcohols containing saturated rings
    • C07C31/133—Monohydroxylic alcohols containing saturated rings monocyclic
    • C07C31/1333—Monohydroxylic alcohols containing saturated rings monocyclic with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7620333A 1975-07-02 1976-07-02 Derives de 16,16-spirocycloalkylprostaglandines, leur preparation et leurs utilisations therapeutiques Withdrawn FR2342724A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/592,494 US4028396A (en) 1975-07-02 1975-07-02 16,16-Spirocycloalkyl prostaglandin derivatives

Publications (1)

Publication Number Publication Date
FR2342724A1 true FR2342724A1 (fr) 1977-09-30

Family

ID=24370883

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7620333A Withdrawn FR2342724A1 (fr) 1975-07-02 1976-07-02 Derives de 16,16-spirocycloalkylprostaglandines, leur preparation et leurs utilisations therapeutiques

Country Status (8)

Country Link
US (1) US4028396A (fr)
JP (1) JPS527941A (fr)
AU (1) AU1532276A (fr)
BE (1) BE843679A (fr)
DE (1) DE2629644A1 (fr)
FR (1) FR2342724A1 (fr)
GB (1) GB1560121A (fr)
NL (1) NL7607337A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2405943A1 (fr) * 1976-11-29 1979-05-11 Merck Patent Gmbh Nouveaux derives de l'acide 13-prostenoique, leur preparation et leur application en tant que medicaments

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293704A (en) * 1975-09-25 1981-10-06 American Cyanamid Company Novel 2-substituted-3,4-epoxycyclopentan-1-ones, 2-substituted-3,4-epoxycyclopentan-1-ols, and various 2-substituted-cyclopentenones
US4117119A (en) * 1975-03-11 1978-09-26 Ono Pharmaceutical Company 15-cyclobutyl-prostaglandins
US4180675A (en) * 1975-07-17 1979-12-25 Warner-Lambert Company 15-Cycloalkyl-prostaglandin derivatives
US4730065A (en) * 1976-07-19 1988-03-08 American Cyanamid Company 15-deoxy-16-hydroxy-16-substituted prostanoic acids and congeners
US4218566A (en) * 1977-03-30 1980-08-19 American Cyanamid Company 11-(2-Hydroxyethylthio) prostenoic acid E and F series derivatives
US4085272A (en) * 1977-03-30 1978-04-18 American Cyanamid Company 11-(2-Hydroxyethylthio)prostenoic acid E2 series derivatives
US4220795A (en) * 1978-08-14 1980-09-02 Miles Laboratories, Inc. Cyclobutyl substituted derivatives of prostaglandin analogs
US4254145A (en) * 1978-08-16 1981-03-03 American Cyanamid Company Topical application of prostaglandin hypotensive agents
US4311707A (en) * 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
WO2008073752A2 (fr) * 2006-12-11 2008-06-19 Allergan, Inc. Composés thérapeutiques
EP2097689A1 (fr) * 2006-12-28 2009-09-09 LG Electronics Inc. Système et procédé de fabrication de glace pour réfrigérateur

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL43571A (en) * 1972-11-08 1977-08-31 Pfizer Omega-pentanorprostaglandins and their preparation
JPS5823393B2 (ja) * 1974-03-14 1983-05-14 オノヤクヒンコウギヨウ カブシキガイシヤ プロスタグランジンルイジカゴウブツ ノ セイゾウホウホウ
GB1484591A (en) * 1974-04-11 1977-09-01 Ono Pharmaceutical Co Prostaglandin compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2405943A1 (fr) * 1976-11-29 1979-05-11 Merck Patent Gmbh Nouveaux derives de l'acide 13-prostenoique, leur preparation et leur application en tant que medicaments

Also Published As

Publication number Publication date
DE2629644A1 (de) 1977-01-20
JPS527941A (en) 1977-01-21
AU1532276A (en) 1978-01-05
BE843679A (fr) 1977-01-03
GB1560121A (en) 1980-01-30
NL7607337A (nl) 1977-01-04
US4028396A (en) 1977-06-07

Similar Documents

Publication Publication Date Title
BE849196A (fr) Derives de l'argininamide, leur preparation et leurs utilisation therapeutiques
BE841537A (fr) Melanges d'aminoalcanols, leur preparation et leurs utilisations
BE868882A (fr) Derives halogenomethyles d'alpha-aminoacides, leur preparation et leurs utilisations therapeutiques
BE843679A (fr) Derives de 16,16-spirocycloalkylprostaglandines, leur preparation et leurs utilisations therapeutiques
FR2330404A1 (fr) Derives de la 1,4-diazepine, leur preparation et leurs utilisations therapeutiques
FR2313930A1 (fr) Derives d'eburnamenine, leur procede de preparation et leurs applications
BE859613A (fr) Derives de steroides leur preparation et leurs utilisations therapeutiques
BE839362A (fr) Derives de la l-(3,4-dihydroxy-phenyl)-2-methyl-alcaline et leur preparation
BE841536A (fr) Melanges d'aminoalcanols, leur preparation et leurs utilisations
FR2318853A1 (fr) Derives de dodecatetraene, leur preparation et leurs utilisations
BE857576A (fr) Derives de la phenothiazine, leur preparation et leurs utilisations therapeutiques
FR2313063A1 (fr) Derives de pyrrolotriazolopyrimidine leur procede de preparation et leurs applications en therapeutique
BE864484A (fr) Benzylpyridimines, leur preparation et leurs utilisations therapeutiques
MC1344A1 (fr) Derives de la pyrrolidine,leur preparation et leurs utilisations therapeutiques
BE859213A (fr) Pyridobenzodiazepinones, leur preparation et leurs utilisations therapeutiques
BE846117A (fr) Derives de 1-oxo-isoindoline, leurs procedes de preparation et leur application
BE868569A (fr) Derives du diphenyle, leur preparation et leurs utilisations therapeutiques
FR2326925A1 (fr) Derives de pyrimidinones, leur preparation et leurs utilisations therapeutiques
FR2378004B2 (fr) Derives de l'argininamide, leur preparation et leurs utilisations therapeutiques
BE868570A (fr) Derives d'acides tetranaphtalenesulfoniques, leur preparation et leurs utilisations therapeutiques
BE865834A (fr) Thiobenzylpyrimidines, leur preparation et leurs utilisations therapeutiques
BE856485A (fr) (2-azabicyclo(2.2.2)octane-2-yl) diphenylalcanones et derives et leur preparation et leurs utilisations therapeutiques
FR2320094A1 (fr) Derives de l'indazole, leur preparation et leurs utilisations therapeutiques
FR2315275A1 (fr) 1-acyl-1,2,3,4-tetrahydro-6-quinoleinols et leur preparation
BE837605A (fr) Derives de 2-aminoacetamindo- -phenyllenzylidene aminoalcanols, leur procede de preparation et leurs applications en therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse